Staffan Encrantz, Director at Sight Sciences, Inc. (SGHT), bought 527,048 shares at $24.00 ($12.6M) on 2021-10-18, disclosed to the SEC on 2021-10-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SGHT | BUY | 2025-06-06 | $646K | — | Filing → |
| SGHT | BUY | 2025-06-03 | $753K | — | Filing → |
| SGHT | BUY | 2025-05-29 | $904K | — | Filing → |